section name header

Y-Site Injection Compatibility (1:1 Mixture)

Hydroxyzine HCl

(Mfr: REN)(Conc: 0.4 mg/mLb)

QMark

Blinatumomab

(Mfr: AMG)(Conc: 0.375 mcg/mLb)

Remarks:

Persistent particulate formation when hydroxyzine is added to blinatumomab; not observed when order of mixing was reversed

Ref:

3405,3417